-
Vyome Announces Executive Management Appointment
americanpharmaceuticalreview
January 13, 2020
Vyome Therapeutics announced the appointment of Craig Tooman as the Chief Operating Officer (COO) and Chief Financial Officer (CFO). Tooman brings more than 25 years of operating, financial, and M&A experience in the biotechnology and pharmaceutical indus
-
AzurRx BioPharma Announces Appointment of Daniel Schneiderman as Chief Financial Officer
firstwordpharma
January 05, 2020
AzurRx BioPharma, Inc. (NASDAQ: AZRX) ("AzurRx" or the "Company"), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that Daniel Schneiderman has been appointed to serve as the
-
Accellix Announces Board of Directors Appointment
americanpharmaceuticalreview
August 16, 2019
Accellix announces the appointment of a new Board Member, Charles (Chuck) Piazza.
-
Athira Pharma Announces COO Appointment
americanpharmaceuticalreview
July 17, 2019
Athira Pharma announced the appointment of Mark Litton, PhD, MBA as Chief Operating Officer.
-
Compugen Announces Board of Directors Appointment
americanpharmaceuticalreview
July 03, 2019
Compugen announced the appointment of Eran Perry to its board of directors, effective July 1, 2019. In addition, the Company announced that Yair Aharonowitz, Ph.D. and Arie Ovadia, Ph.D. will retire from its board of directors and will not be brought for
-
Many Buprenorphine Prescribers Not Offering New Appointments
drugs
June 04, 2019
Many buprenorphine prescribers not offering new appointments.
-
Lannett Announces Board of Directors Appointment
americanpharmaceuticalreview
May 24, 2019
Lannett announced the appointment of Melissa V. Rewolinski, PhD, to its board of directors, effective July 1, 2019. Following the appointment of Dr. Rewolinski, the board will comprise eight directors.
-
Aptorum Group Limited announces appointment of Head of R&D and COO
biospectrumasia
April 03, 2019
Aptorum Group Limited has announced the appointment of Dr. Thomas Wai-yip Lee as Head of Research and Development and Dr. Angel Siu-yan Ng as Chief Operating Officer of Aptorum, effective on April 1, 2019.
-
Lupin appoints Christine Mundkur as Independent Director
expressbpd
April 03, 2019
She most recently served as Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc
-
Glenmark appoints Alessandro Riva as CEO of its new innovation company in US
expressbpd
March 07, 2019
The appointment is effective April 2, 2019